3PBIOVIAN Team, Author at 3PBIOVIAN - Page 2 of 6

Advanced Therapies UK

November 6, 2025

Phacilitate’s Advanced Therapies Week US

November 6, 2025

3PBIOVIAN, awarded at the Cegos Awards 2025 for its AI-driven talent management model

October 20, 2025

From Research Stage to GMP Production

October 14, 2025

Virginia Sancho: Advancing Quality by Design in Biotechnology

September 26, 2025

3PBIOVIAN MOBILITY PROGRAM

September 26, 2025

On-Demand Webinar: Enabling CTA Submission in Record Time

August 28, 2025

LSC-Adenovirus-Webinar-Speakers

Webinar: Enabling CTA Submission in Record time:

July 31, 2025

Announcement of 3PBIOVIAN attending ESGCT 2025 in Seville, focused on viral vectors and plasmid DNA manufacturing

ESGCT 2025 Annual Congress

July 22, 2025

3PBIOVIAN announces presence at Nordic Life Science Days 2025 in Gothenburg, showcasing integrated CDMO capabilities

Nordic Life Science Days 2025

July 22, 2025

3PBIOVIAN team at BIO-Europe 2025 booth C63 in Vienna, showcasing CDMO services for biologics and advanced therapies.

BIO-Europe 2025

July 22, 2025

Announcement of 3PBIOVIAN's participation in Cell & Gene Meeting 2025 in Phoenix, focused on advanced therapies

Cell & Gene Meeting on the Mesa

July 22, 2025

Why Embrace Learning Empowerment in Biopharma? Insights from 3PBIOVIAN’s Talent Development Journey

July 21, 2025

Why Embrace Diversity, Equity, And Inclusion (DEI) In The CDMO/Biopharma Sector: Insights From 3PBIOVIAN’s Journey

June 24, 2025

New Expert Insight Articles Available on Cell & Gene

New Expert Insight Articles Available on Cell & Gene

June 18, 2025

Elena Erroba Assumes Representation of 3PBIOVIAN on the AseBio Board of Directors

May 27, 2025

« Previous 1 2 3 4 … 7 Next »